PROC (Procaps Group Corp) Total Enterprise Value

Procaps Group Corp - graphic logo of issuer PROC

This chart of Procaps Group S.A. (PROC) stock quotes reflects the valuation of a business supported by a network of modern plants in the US and Latin America. The current figure stands at , although the debts of South American sites and reporting risks are weighing on margins. Proprietary capsule developments, which generate regular licensing fees and assembly orders, sustain the company's stability.

PROC (procapsgroup.com) Total Company Value history from 07/04/2022 to 10/27/2026
Original product of Procaps Group S.A.

Enterprise value combines market capitalization with net debt, determining the total buyout price of a business accounting for all liabilities and liquidity. By analyzing the calculated enterprise value, an investor can see how the capsule production outsourcing strategy reduces capital expenditures for Procaps Group S.A. (PROC), which optimizes the overall asset value and minimizes the risk of overpaying for redundant physical capacity.

Competitor analysis for Procaps Group S.A.

Haleon PLC - Value Adjusted for Debt and Cash|KVUE (Kenvue Corp) - Total Company Value|VRNA - Total Enterprise Value|MENS (Jyong Biotech Ltd) - Enterprise Value|LGND (ligand.com) - Real Price to Acquire Entire Company|Total Company Value Amneal AMRX|Full Business Value Perrigo Company PLC|Alvotech Corp (ALVO) - Enterprise Value|Value Adjusted for Debt and Cash Liquidia Inc. (LQDA)|Enterprise Value GLPG (Galapagos NV)|anipharmaceuticals.com - Enterprise Value|Total Company Value MannKind (MNKD)|AMPH: Value Adjusted for Debt and Cash|PCRX (Pacira) - Total Company Value|ARS Corp (SPRY) - Real Price to Acquire Entire Company|TBPH (Theravance Biopharma) - Enterprise Value|Enterprise Value aquestive.com (AQST)|scPharmaceuticals Inc. (SCPH) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash TECX (tectonictx.com)|TNXP: Total Company Value|SXTC - Total Enterprise Value|Real Price to Acquire Entire Company Eupraxia Pharma EPRX|BHST - Aggregate Business Value|Enterprise Value eXoZymes EXOZ|Oramed Pharmaceuticals Inc. (ORMP) - Value Adjusted for Debt and Cash|Enterprise Value ENTX (Entera Bio Ltd)|Total Enterprise Value HYFT|ABVC BioPharma (ABVC) - Total Company Value|Value Adjusted for Debt and Cash CPIX (cumberlandpharma.com)|Quantum BioPharma (QNTM) - Total Company Value|FibroGen Inc - Full Business Value|Total Company Value Telomir Pharma (TELO)|RANI: Value Adjusted for Debt and Cash|Total Company Value SNYR|Rallybio (RLYB) - Total Enterprise Value|Enterprise Value LEXX|Real Price to Acquire Entire Company Pulmatrix Inc|Enterprise Value PTHL|Enterprise Value APM (aptorumgroup.com)|Lyra Therapeutics, Inc. (LYRA) - Total Company Value|Impact BioMedical, Inc. - Full Business Value|Total Company Value TNFA (TNF Pharma)|cbdMD, Inc. (YCBD) - Company Buyout Price|Real Price to Acquire Entire Company PainReform Limited PRFX|Altamira Therapeutics Ltd. (CYTO) - Value Adjusted for Debt and Cash|Lipella Pharmaceuticals - Enterprise Value|Full Takeover Company Value OPTN|Pieris Pharmaceuticals, Inc. (PIRS) - Total Company Value|Value Adjusted for Debt and Cash PTPI (Petros Pharmaceuticals Inc)|QLI: Total Company Value|SLRN - Total Enterprise Value|TFF Pharmaceuticals - Real Price to Acquire Entire Company